Synairgen Share Discussion Threads

[bmnsa] 14/5/2020 10:20

I'm back to 70% cash
Markets will see a total bloodbath shortly

[peachie 74] 14/5/2020 10:19

Put a biggish buy in at 56 and not showing.
Bloody cloak and daggers

[paradise city] 14/5/2020 10:15

Imo I'd take the fool's advice with a pinch of salt !

[makendon] 14/5/2020 10:13

Motley Fool post from yesterday



The Synairgen (LSE: SNG) share price has almost ten-bagged since the beginning of 2020. The company has a potential Covid-19 treatment, known as SNG001, so no surprise there. What’s more, on 18 March the firm released details of its testing plans. It’s not a coronavirus vaccine, but it could possibly be the next best thing.

SNG001 is a based on an existing intravenous antiviral treatment. And Synairgen’s new inhaler version will deliver the drug directly to the lungs, where the coronavirus does its damage. This stuff sounds like it could be a potential lifesaver. As it’s based on an existing well-tested treatment, the trial and approval process could potentially be a lot quicker than for any coronavirus vaccine or treatment being developed from scratch.

Claim your FREE copy of The Motley Fool’s Bear Market Survival Guide.
Global stock markets may be reeling from the coronavirus, but you don’t have to face this down market alone. Help yourself to a FREE copy of The Motley Fool’s Bear Market Survival Guide and discover the five steps you can take right now to try and bolster your portfolio… including how you can aim to turn today’s market uncertainty to your advantage. Click here to claim your FREE copy now!
The testing started at the end of March. Synairgen CEO Richard Marsde said: “A successful outcome from this trial in Covid-19 patients would be a major breakthrough in the fight against this coronavirus pandemic.” Let’s hope that turns out to be an understatement.

Coronavirus vaccine candidates

In a report last month, IG.com examined 14 companies developing coronavirus vaccines and treatments. Many have seen their share prices soar, but the report points out that they won’t all succeed. The World Health Organization reckons there are more than 50 coronavirus vaccine candidates currently at various stages of development. We might see a small number of those making it through to production and big sales. But how can we decide which those will be? I can’t really see any other viable approach than guesswork.

Most of the companies examined by IG.com are based in the US, unsurprisingly, and one of them sounds like it might have a potential advantage. Inovio Pharmaceuticals already has a vaccine for the MERS coronavirus, and I’d assume that would be a great help. Inovio is hoping to deliver a million doses by the end of the year. But its share price is up only a relatively modest 290% so far this year. Investors seem to be more excited by Synairgen.

UK virus investment

GlaxoSmithKline (LSE: GSK) is in the race too, providing its expertise in adjuvants to companies doing coronavirus vaccine research. I’d never heard of adjuvants before today, but they’re things that can be added to vaccines to boost their effectiveness. They sound like a sort of pharmacological catalyst to me.

GlaxoSmithKline is surely not going to turn into a multibagger any time soon. Though if you’re looking for sure-fire short-term profits, I really can’t help you. But what I do like about GlaxoSmithKline’s involvement is that it makes it something of a ‘picks and shovels’ investment. You know, from the old gold rush days, when no matter who found the shiny stuff, those who sold the tools made nice profits.

Quick growth punt?

Should you take a punt on Synairgen, or any other coronavirus vaccine possibilities? As long as you understand the risk and you’re prepared for a loss if you get the wrong one, I don’t see a problem with investing a small amount of money. But I’d always recommend putting the bulk of your investment cash into long-term quality like GlaxoSmithKline. So in answer to my question in the headline: yes, you might get rich. But you might not. I’d rather go for steady returns compounded over time from a long-term holding in GSK.

[vitec] 14/5/2020 09:30

I do not want to comment on PREM on the SNG board. If you want my views go to the PREM BB.

[vitec] 14/5/2020 09:28

Yeah. Got some way to go though!!

[cambradjones] 14/5/2020 09:22

Vitec At least prem going again for you !

[vitec] 14/5/2020 09:16

I have always stated that MM's make the market and make their money from buying and selling.

[d1nga] 14/5/2020 09:13

Wrong

MM
Simply make the market it makes no difference what direction the price is going.

[vitec] 14/5/2020 09:10

peachie, we are at the bottom of the food chain. Bigger players, MM's and others have an advantage as they have the ability to understand far more then we will ever. They have money, research, sophisticated tools and a whole range of abilities that no PI has. What they cannot control is a double blinded trial. They, like us have to wait for the results and unless they are trying to get information in an underhanded way they have no idea of what the result will be. On that basis it is a fair playing field and they will either make money or lose money, like me and you and everyone else on that basis.

[vitec] 14/5/2020 09:02

It is hard to determine exactly what is going on because of the delayed trades. Need to see the delayed trades in the next hour to get a better picture.

My opinion for what it is worth is there are not a lot of sellers but equally there are not a lot of buyers.

[cambradjones] 14/5/2020 09:00

I hear you peachie !Everyday without fail the first 30 mins of trading see's loads of red trades and we are down 5%, today for a very rare change we see solid blue trades for 30mins........ and we are down...........arghhh !

[vitec] 14/5/2020 08:58

Nobody likes uncertainty when they are trading/investing. That is why seeing the bigger picture and being patient is so important. We are at the behest of MM's that will be reactive to the orders they have placed with them. On a thin volume day they will also be cautious. They know if they start to "push" the share price upwards they will have a surge of momentum buying that may catch them out. As we get closer and closer to an announcement they will not want to oversell stock as they may not be able to buy it back at a reasonable price.

I have said it before the share price is being managed. It is walked down and ran up. This is part and parcel of trading.

[peachie 74] 14/5/2020 08:49

Price drop on what visibly appears loads more buys than sells. Stacking up the sells to show letter. Ffs. Sorry to moan but this is taking the p!!!
I mean look at that chart. It’s like an ECG of a massive heart attack .... very appropriate !

Hopefully holders will look back in a few weeks and laugh about this frustrating period !!

[adman50] 14/5/2020 08:39

Vitec I retract my statement 🤣

Noticed this morning our good friend Floyd is still terrorising the other board it amazes me people take the bait.

[tburns] 14/5/2020 08:39

Tomorrow is Thursday due to last Fridays bank holiday in effect, will be blue tomorrow, probably drip a little again today me thinks!

[vitec] 14/5/2020 08:34

I have resisted saying it. Let's see what happens.

[pdt] 14/5/2020 08:34

Interesting news release;

BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19



The study investigated the use of interferon alpha-2b on 77 patients with moderate cases of COVID-19 and found that the interferon alpha-2b drug significantly accelerated clearance of the virus from the airways of patients.

[adman50] 14/5/2020 08:31

We didn't get one last week so I'm gonna say we gonna get a blue Thursday today. (albeit s small one)

[bmnsa] 14/5/2020 08:30

Fill yer boots.

[vitec] 14/5/2020 08:29

Now offering 55.6p. Very thin volumes.

[dave444] 14/5/2020 08:22

55.75 was the last sellThey maybe offering higher now

[vitec] 14/5/2020 08:20

All the trades at 56.2p are sells. MM's happy to take 30k off me at 56.2p.